Financial reports
ARS
2023 FY
Annual report to shareholders
24 Apr 24
10-K
2023 FY
Annual report
27 Mar 24
20-F
2022 FY
Annual report (foreign)
28 Mar 23
20-F
2021 FY
Annual report (foreign)
31 Mar 22
20-F
2020 FY
Annual report (foreign)
31 Mar 21
20-F
2019 FY
Annual report (foreign)
15 Jun 20
20-F/A
2018 FY
Annual report (foreign) (amended)
29 May 19
20-F
2018 FY
Annual report (foreign)
29 Apr 19
Current reports
8-K
Entry into a Material Definitive Agreement
15 Apr 24
8-K
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
27 Mar 24
8-K
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
8 Jan 24
6-K
Current report (foreign)
18 Dec 23
6-K
Current report (foreign)
29 Nov 23
6-K
Current report (foreign)
16 Nov 23
6-K
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
23 Oct 23
6-K
Current report (foreign)
17 Oct 23
6-K
Current report (foreign)
20 Sep 23
6-K
Current report (foreign)
7 Sep 23
Registration and prospectus
S-8
Registration of securities for employees
23 Jan 24
8-A12B/A
Registration of securities on exchange (amended)
18 Dec 23
S-8
Registration of securities for employees
24 Jan 23
8-A12B/A
Registration of securities on exchange (amended)
17 May 22
S-8
Registration of securities for employees
13 Jan 22
F-3/A
Shelf registration (foreign) (amended)
27 Sep 21
F-3/A
Shelf registration (foreign) (amended)
7 Sep 21
F-6EF
Automatic registration for ADRs (foreign)
13 Aug 21
F-3
Shelf registration (foreign)
5 Aug 21
424B5
Prospectus supplement for primary offering
10 Feb 21
Other
UPLOAD
Letter from SEC
24 Aug 22
CORRESP
Correspondence with SEC
19 Aug 22
UPLOAD
Letter from SEC
8 Aug 22
CT ORDER
Confidential treatment order
10 Jun 22
EFFECT
Notice of effectiveness
1 Oct 21
CORRESP
Correspondence with SEC
29 Sep 21
UPLOAD
Letter from SEC
21 Sep 21
CORRESP
Correspondence with SEC
7 Sep 21
UPLOAD
Letter from SEC
20 Aug 21
EFFECT
Notice of effectiveness
22 Oct 20
Ownership
SC 13D/A
Rubric Capital Management LP
16 Apr 24
SC 13G/A
ORBIMED ADVISORS LLC
14 Feb 24
SC 13G/A
Rock Springs Capital Management LP
14 Feb 24
SC 13G/A
Rock Springs Capital Management LP
14 Feb 24
SC 13G
MANGROVE PARTNERS IM, LLC
14 Feb 24
SC 13G/A
SUVRETTA CAPITAL MANAGEMENT, LLC
13 Feb 24
4
Anders Ekblom
9 Feb 24
4
Pierre Jacquet
9 Feb 24
4
Marc J Yoskowitz
9 Feb 24
4
DEEPIKA PAKIANATHAN
9 Feb 24